The global Nucleic Acid Amplification Testing market was valued at US$ 133.5 million in 2023 and is anticipated to reach US$ 184.9 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
North American market for Nucleic Acid Amplification Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nucleic Acid Amplification Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Nucleic Acid Amplification Testing in Infectious Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Nucleic Acid Amplification Testing include Roche, Becton Dickinson, Beckman Coulter, Abbott, Illumina, Siemens Healthineers, bioMerieux, Novartis and Bio-Rad Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Amplification Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Amplification Testing.
Report Scope
The Nucleic Acid Amplification Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid Amplification Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Amplification Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Becton Dickinson
Beckman Coulter
Abbott
Illumina
Siemens Healthineers
bioMerieux
Novartis
Bio-Rad Laboratories
Segment by Type
Target Amplification Systems
Probe Amplification Systems
Signal Amplification
Segment by Application
Infectious Diseases
Cancer
Personalized Medicine
Genetic and Mitochondrial Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Amplification Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Amplification Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Target Amplification Systems
1.2.3 Probe Amplification Systems
1.2.4 Signal Amplification
1.3 Market by Application
1.3.1 Global Nucleic Acid Amplification Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Diseases
1.3.3 Cancer
1.3.4 Personalized Medicine
1.3.5 Genetic and Mitochondrial Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Amplification Testing Market Perspective (2019-2030)
2.2 Nucleic Acid Amplification Testing Growth Trends by Region
2.2.1 Global Nucleic Acid Amplification Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nucleic Acid Amplification Testing Historic Market Size by Region (2019-2024)
2.2.3 Nucleic Acid Amplification Testing Forecasted Market Size by Region (2025-2030)
2.3 Nucleic Acid Amplification Testing Market Dynamics
2.3.1 Nucleic Acid Amplification Testing Industry Trends
2.3.2 Nucleic Acid Amplification Testing Market Drivers
2.3.3 Nucleic Acid Amplification Testing Market Challenges
2.3.4 Nucleic Acid Amplification Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Amplification Testing Players by Revenue
3.1.1 Global Top Nucleic Acid Amplification Testing Players by Revenue (2019-2024)
3.1.2 Global Nucleic Acid Amplification Testing Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid Amplification Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Amplification Testing Revenue
3.4 Global Nucleic Acid Amplification Testing Market Concentration Ratio
3.4.1 Global Nucleic Acid Amplification Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Amplification Testing Revenue in 2023
3.5 Nucleic Acid Amplification Testing Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Amplification Testing Product Solution and Service
3.7 Date of Enter into Nucleic Acid Amplification Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Amplification Testing Breakdown Data by Type
4.1 Global Nucleic Acid Amplification Testing Historic Market Size by Type (2019-2024)
4.2 Global Nucleic Acid Amplification Testing Forecasted Market Size by Type (2025-2030)
5 Nucleic Acid Amplification Testing Breakdown Data by Application
5.1 Global Nucleic Acid Amplification Testing Historic Market Size by Application (2019-2024)
5.2 Global Nucleic Acid Amplification Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nucleic Acid Amplification Testing Market Size (2019-2030)
6.2 North America Nucleic Acid Amplification Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nucleic Acid Amplification Testing Market Size by Country (2019-2024)
6.4 North America Nucleic Acid Amplification Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Amplification Testing Market Size (2019-2030)
7.2 Europe Nucleic Acid Amplification Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nucleic Acid Amplification Testing Market Size by Country (2019-2024)
7.4 Europe Nucleic Acid Amplification Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Amplification Testing Market Size (2019-2030)
8.2 Asia-Pacific Nucleic Acid Amplification Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nucleic Acid Amplification Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Nucleic Acid Amplification Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Amplification Testing Market Size (2019-2030)
9.2 Latin America Nucleic Acid Amplification Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nucleic Acid Amplification Testing Market Size by Country (2019-2024)
9.4 Latin America Nucleic Acid Amplification Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Amplification Testing Market Size (2019-2030)
10.2 Middle East & Africa Nucleic Acid Amplification Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nucleic Acid Amplification Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Nucleic Acid Amplification Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Nucleic Acid Amplification Testing Introduction
11.1.4 Roche Revenue in Nucleic Acid Amplification Testing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Detail
11.2.2 Becton Dickinson Business Overview
11.2.3 Becton Dickinson Nucleic Acid Amplification Testing Introduction
11.2.4 Becton Dickinson Revenue in Nucleic Acid Amplification Testing Business (2019-2024)
11.2.5 Becton Dickinson Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Detail
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Nucleic Acid Amplification Testing Introduction
11.3.4 Beckman Coulter Revenue in Nucleic Acid Amplification Testing Business (2019-2024)
11.3.5 Beckman Coulter Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Nucleic Acid Amplification Testing Introduction
11.4.4 Abbott Revenue in Nucleic Acid Amplification Testing Business (2019-2024)
11.4.5 Abbott Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Nucleic Acid Amplification Testing Introduction
11.5.4 Illumina Revenue in Nucleic Acid Amplification Testing Business (2019-2024)
11.5.5 Illumina Recent Development
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Company Detail
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Nucleic Acid Amplification Testing Introduction
11.6.4 Siemens Healthineers Revenue in Nucleic Acid Amplification Testing Business (2019-2024)
11.6.5 Siemens Healthineers Recent Development
11.7 bioMerieux
11.7.1 bioMerieux Company Detail
11.7.2 bioMerieux Business Overview
11.7.3 bioMerieux Nucleic Acid Amplification Testing Introduction
11.7.4 bioMerieux Revenue in Nucleic Acid Amplification Testing Business (2019-2024)
11.7.5 bioMerieux Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Nucleic Acid Amplification Testing Introduction
11.8.4 Novartis Revenue in Nucleic Acid Amplification Testing Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Detail
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Nucleic Acid Amplification Testing Introduction
11.9.4 Bio-Rad Laboratories Revenue in Nucleic Acid Amplification Testing Business (2019-2024)
11.9.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Roche
Becton Dickinson
Beckman Coulter
Abbott
Illumina
Siemens Healthineers
bioMerieux
Novartis
Bio-Rad Laboratories
听
听
*If Applicable.
